The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Complement and Its Receptors: New Insights into Human Disease
Open accessAbstract
Although new activation and regulatory mechanisms are still being identified, the basic architecture of the complement system has been known for decades. Two major roles of complement are to control certain bacterial infections and to promote clearance of apoptotic cells. In addition, although inappropriate complement activation has long been proposed to cause tissue damage in human inflammatory and autoimmune diseases, whether this is indeed true has been uncertain. However, recent studies in humans, especially those using newly available biological therapeutics, have now clearly demonstrated the pathophysiologic importance of the complement system in several rare diseases. Beyond these conditions, recent genetic studies have strongly supported an injurious role for complement in a wide array of human inflammatory, degenerative, and autoimmune diseases. This review includes an overview of complement activation, regulatory, and effector mechanisms. It then focuses on new understandings gained from genetic studies, ex vivo analyses, therapeutic trials, and animal models as well as on new research opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional inducers of low-grade inflammation are nutrients and metabolites acting as DAMPs (e.g., free fatty acids, oxidized lipoproteins) and commensal bacteria representing a source of PAMPs [sometimes also described with the more global term microbe-associated molecular patterns (MAMPs), as they are not necessarily pathogenic] (189, 240, 244, 295, 329, 347).”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [240]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 3×
“Additionally, the recently recognized roles of complement in homeostasis point to several nontraditional functions that bridge immunity and developmental biology (12).”
BackgroundInfluentialEvolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,711
C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
Dempsey, P. W., Allison, M. E. D., Akkaraju, S., Goodnow, C. C., & Fearon, D. T. (1996) · Science · doi:10.1126/science.271.5247.348 · Cited by 1,197
Generation of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M. S., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 976
MOLECULAR ORGANIZATION AND FUNCTION OF THE COMPLEMENT SYSTEM
Müller‐Eberhard, H. J. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001541 · Cited by 856
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778 · cited 2×
“On red blood cells, the absence of DAF allows alternative pathway–initiated complement activation by C3 and C5 convertases; the absence of CD59 allows activated C5 to proceed to form the MAC, resulting in intravascular hemolysis (102, 103).”
BackgroundModulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C. J., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 770
Molecular Intercommunication between the Complement and Coagulation Systems
Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F. T., Lambris, J. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903678 · Cited by 719
Research works printed but not linked: 6
- Holers VM, 1989, Year Immunol., 4, 231
- Song JJ, 2011, J. Clin. Investig., 121, 3517
- Rose KL, 2008, J. Clin. Investig., 118, 608
- Calero I, 2010, Discov. Med., 10, 416
- He S, 2009, J. Clin. Investig., 119, 2304
- Thurman JM, J. Clin. Investig., 123, 2103
Cited by
Sorted by citations
The Sleep-Immune Crosstalk in Health and Disease
Besedovsky, L., Lange, T., & Haack, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00010.2018 · Cited by 1,479
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.010 · Cited by 799
Lian, H., Yang, L., Cole, A., Sun, L., Chiang, A. C.-A., Fowler, S. W., Shim, D. J., Rodriguez-Rivera, J., Taglialatela, G., Jankowsky, J. L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.018 · Cited by 697
Klebsiella pneumoniae infection biology: living to counteract host defences
Bengoechea, J. A., & Sá‐Pessoa, J. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy043 · Cited by 605
The role of the complement system in cancer
Afshar‐Kharghan, V. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90962 · Cited by 565
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
Jaffe, G. J., Westby, K., Csaky, K. G., Monés, J., Pearlman, J. A., Patel, S. S., Joondeph, B. C., Randolph, J. C., Masonson, H., & Rezaei, K. A. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.08.027 · Cited by 494
New insights into the immune functions of complement
Reis, E. S., Mastellos, D. C., Hajishengallis, G., & Lambris, J. D. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0168-x · Cited by 485
Hepatocytes: a key cell type for innate immunity
Zhou, Z., Xu, M.-J., & Gao, B. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.97 · Cited by 472
Staphylococcus aureusSecreted Toxins and Extracellular Enzymes
Tam, K., & Torres, V. J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0039-2018 · Cited by 513
Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion
Verkhratsky, A., Matteoli, M., Parpura, V., Mothet, J., & Zorec, R. (2016) · The EMBO Journal · doi:10.15252/embj.201592705 · Cited by 397
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Ramlall, V., Thangaraj, P., Meydan, C., Foox, J., Butler, D., Kim, J., May, B., Freitas, J. K. D., Glicksberg, B. S., Mason, C. E., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1021-2 · Cited by 356
Immunomodulatory Biomaterials for Tissue Repair
Whitaker, R. C., Hernaez‐Estrada, B., Hernández, R. M., Santos‐Vizcaíno, E., & Spiller, K. L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00895 · Cited by 347
Nanoparticles and innate immunity: new perspectives on host defence
Boraschi, D., Italiani, P., Palomba, R., Decuzzi, P., Duschl, A., Fadeel, B., & Moghimi, S. M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.013 · Cited by 310
The interaction of innate immune and adaptive immune system
Wang, R., Lan, C., Benlagha, K., Câmara, N. O. S., Miller, H. E., Kubo, M., Heegaard, S., Lee, P. P. W., Yang, L., Forsman, H. F., et al. (2024) · MedComm · doi:10.1002/mco2.714 · Cited by 395
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
Quast, I., Keller, C. W., Maurer, M., Giddens, J. P., Tackenberg, B., Wang, L., Münz, C., Nimmerjahn, F., Dalakas, M. C., & Lünemann, J. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82695 · Cited by 270
Scriba, T. J., Penn‐Nicholson, A., Shankar, S., Hraha, T., Thompson, E. G., Sterling, D., Nemes, E., Darboe, F., Suliman, S., Amon, L. M., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006687 · Cited by 255
Antimicrobial bacteriophage-derived proteins and therapeutic applications
Roach, D. R., & Donovan, D. M. (2015) · Bacteriophage · doi:10.1080/21597081.2015.1062590 · Cited by 246
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Galipeau, Y., Greig, M., Liu, C., Driedger, M., & Langlois, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610688 · Cited by 247
Zeng, Z., Surewaard, B. G. J., Wong, C. H. Y., Geoghegan, J. A., Jenne, C. N., & Kubes, P. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.06.002 · Cited by 229
Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system
Honda, M., & Kubes, P. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.183 · Cited by 230
Peschke, B., Keller, C. W., Weber, P., Quast, I., & Lünemann, J. D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00646 · Cited by 227
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Garred, P., Tenner, A. J., & Mollnes, T. E. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000072 · Cited by 219
Phagocytosis of Necrotic Debris at Sites of Injury and Inflammation
Westman, J., Grinstein, S., & Marques, P. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03030 · Cited by 214
Fischinger, S., Fallon, J. K., Michell, A. R., Broge, T. A., Suscovich, T. J., Streeck, H., & Alter, G. (2019) · Journal of Immunological Methods · doi:10.1016/j.jim.2019.07.002 · Cited by 201
The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential
Zhang, X., Liu, H., Hashimoto, K., Yuan, S., & Zhang, J. (2022) · Critical Care · doi:10.1186/s13054-022-04090-1 · Cited by 200
Neutrophil-Mediated Phagocytosis of Staphylococcus aureus
van Kessel, K. P. M., Bestebroer, J., & van Strijp, J. A. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00467 · Cited by 208
Complement receptors and their role in leukocyte recruitment and phagocytosis
Vandendriessche, S., Cambier, S., Proost, P., & Marques, P. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.624025 · Cited by 178
Receptor-Mediated NETosis on Neutrophils
Chen, T., Li, Y., Sun, R., Hu, H., Liu, Y., i, M. H., Zhao, Y., & Munoz, L. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.775267 · Cited by 173
Compendium of current complement therapeutics
Zelek, W. M., Xie, L., Morgan, B. P., & Harris, C. L. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.07.030 · Cited by 162
The “ins and outs” of complement‐driven immune responses
Freeley, S. J., Kemper, C., & Friec, G. L. (2016) · Immunological Reviews · doi:10.1111/imr.12472 · Cited by 166
Salabarria, S. M., Corti, M., Coleman, K. E., Wichman, M. B., Berthy, J. A., D’Souza, P., Tifft, C. J., Herzog, R. W., Elder, M. E., Shoemaker, L. R., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci173510 · Cited by 159
Complement activation and endothelial perturbation parallel COVID-19 severity and activity
Cugno, M., Meroni, P. L., Gualtierotti, R., Griffini, S., Grovetti, E., Torri, A., Lonati, P. A., Grossi, C., Borghi, M. O., Novembrino, C., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102560 · Cited by 163
Why do we study animal toxins?
Zhang, Y. (2015) · PubMed Central · doi:10.13918/j.issn.2095-8137.2015.4.183 · Cited by 160
Complement in the Initiation and Evolution of Rheumatoid Arthritis
Holers, V. M., & Banda, N. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01057 · Cited by 152
Self-citationMyasthenia gravis: the changing treatment landscape in the era of molecular therapies
Iorio, R. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00916-w · Cited by 140
Role of the complement system in the tumor microenvironment
Zhang, R., Liu, Q., Li, T., Liao, Q., & Zhao, Y. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1027-3 · Cited by 127
Soltys, J. N., Liu, Y., Ritchie, A. M., Wemlinger, S. M., Schaller, K., Schumann, H., Owens, G. P., & Bennett, J. L. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122942 · Cited by 133
Complement in therapy and disease
Melis, J. P. M., Strumane, K., Ruuls, S. R., Beurskens, F. J. M., Schuurman, J., & Parren, P. W. H. I. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.028 · Cited by 134
Martin, M., Leffler, J., Smoląg, K. I., Mytych, J., Björk, A., Chaves, L. D., Alexander, J. J., Quigg, R. J., & Blom, A. M. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2015.164 · Cited by 120
Complement Inhibitors in Clinical Trials for Glomerular Diseases
Zipfel, P. F., Wiech, T., Rudnick, R. B., Afonso, S., Person, F., & Skerka, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02166 · Cited by 118
Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes
Hamilton, B. A., & Wright, J. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.675897 · Cited by 116
Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper
Yang, T., Braun, M., Lembke, W., McBlane, F., Kamerud, J., DeWall, S. L., Tarcsa, E., Fang, X., Hofer, L., Kavita, U., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.07.018 · Cited by 122
Properdin: a tightly regulated critical inflammatory modulator
Blatt, A. Z., Pathan, S., & Ferreira, V. P. (2016) · Immunological Reviews · doi:10.1111/imr.12466 · Cited by 113
Analysis of the Complement System in the Clinical Immunology Laboratory
Ling, M. F., & Murali, M. R. (2019) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2019.07.006 · Cited by 113
Complement regulator CD46: genetic variants and disease associations
Liszewski, M. K., & Atkinson, J. P. (2015) · Human Genomics · doi:10.1186/s40246-015-0029-z · Cited by 111
Fungal glycans and the innate immune recognition
Barreto‐Bergter, E., & Figueiredo, R. T. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00145 · Cited by 115
The complement cascade in the regulation of neuroinflammation, nociceptive sensitization, and pain
Warwick, C. A., Keyes, A. L., Woodruff, T. M., & Usachev, Y. M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101085 · Cited by 118
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer
Meyer, S., Leusen, J. H. W., & Boross, P. (2014) · mAbs · doi:10.4161/mabs.29670 · Cited by 110
Fukuzawa, T., Sampei, Z., Haraya, K., Ruike, Y., Shida-Kawazoe, M., Shimizu, Y., Gan, S. W., Irie, M., Tsuboi, Y., Tai, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01087-7 · Cited by 107
Overcoming Nanoparticle-Mediated Complement Activation by Surface PEG Pairing
Pannuzzo, M., Esposito, S. A., Wu, L., Key, J., Aryal, S., Celia, C., di Marzio, L., Moghimi, S. M., & Decuzzi, P. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01011 · Cited by 105
Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control
Prohászka, Z., Nilsson, B., Frazer‐Abel, A. A., & Kirschfink, M. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.06.008 · Cited by 104
Protein Termini and Their Modifications Revealed by Positional Proteomics
Marino, G., Eckhard, U., & Overall, C. M. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00189 · Cited by 103
Miyabe, Y., Miyabe, C., Murooka, T. T., Kim, E. Y., Newton, G. A., Kim, N. D., Haribabu, B., Luscinskas, F. W., Mempel, T. R., & Luster, A. D. (2017) · Science Immunology · doi:10.1126/sciimmunol.aaj2195 · Cited by 100
Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery
Malachowski, T., & Hassel, A. (2020) · Engineered Regeneration · doi:10.1016/j.engreg.2020.06.001 · Cited by 99
The impact of protein corona on the biological behavior of targeting nanomedicines
Farshbaf, M., Valizadeh, H., Panahi, Y., Fatahi, Y., Chen, M., Zarebkohan, A., & Gao, H. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121458 · Cited by 95
Complement Evasion: An Effective Strategy That Parasites Utilize to Survive in the Host
Shao, S., Sun, X., Chen, Y., Zhan, B., & Zhu, X. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00532 · Cited by 94
Pestrak, M. J., Baker, P., Dellos-Nolan, S., Hill, P. J., da Silva, D. P., Silver, H. D., Lacdao, I., Raju, D., Parsek, M. R., Wozniak, D. J., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00234-19 · Cited by 94
The multifaceted impact of complement on atherosclerosis
Kiss, M. G., & Binder, C. J. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.014 · Cited by 97
Developments in anti-complement therapy; from disease to clinical trial
Harris, C. L., Pouw, R. B., Kavanagh, D., Sun, R., & Ricklin, D. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.008 · Cited by 93
Properdin: A multifaceted molecule involved in inflammation and diseases
Chen, J. Y., Cortés, C., & Ferreira, V. P. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.05.018 · Cited by 93
Targeting the Sugary Armor of Klebsiella Species
Patro, L. P. P., & Rathinavelan, T. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00367 · Cited by 87
Zinellu, A., & Mangoni, A. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696085 · Cited by 82
Scherer, H. U., van der Woude, D., & Toes, R. E. M. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00786-4 · Cited by 85
Kiss, M. G., Papac-Miličević, N., Porsch, F., Tsiantoulas, D., Hendrikx, T., Takaoka, M., Dinh, H. Q., Narzt, M., Göderle, L., Ozsvár-Kozma, M., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.026 · Cited by 87
Shutov, L. P., Warwick, C. A., Shi, X., Gnanasekaran, A., Shepherd, A. J., Mohapatra, D. P., Woodruff, T. M., Clark, J. D., & Usachev, Y. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3249-15.2016 · Cited by 85
Marginal zone B cells acquire dendritic cell functions by trogocytosis
Schriek, P., Ching, A. C., Moily, N. S., Moffat, J. M., Beattie, L., Steiner, T. M., Hosking, L. M., Thurman, J. M., Holers, V. M., Ishido, S., et al. (2022) · Science · doi:10.1126/science.abf7470 · Cited by 88
Self-citationCatenacci, L., Rossi, R., Sechi, F., Buonocore, D., Sorrenti, M., Perteghella, S., Peviani, M., & Bonferoni, M. C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121521 · Cited by 86
Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab
Verhave, J. C., Wetzels, J. F. M., & van de Kar, N. C. A. J. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu235 · Cited by 79
Leaker, B. R., Malkov, V., Mogg, R., Ruddy, M., Nicholson, G. C., Tan, A. J., Tribouley, C., Chen, G., Lepeleire, I. D., Calder, N. A., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.74 · Cited by 80
Bacteriophage and the Innate Immune System: Access and Signaling
Carroll‐Portillo, A., & Lin, H. C. (2019) · Microorganisms · doi:10.3390/microorganisms7120625 · Cited by 83
Unintended effects of drug carriers: Big issues of small particles
Parhiz, H., Khoshnejad, M., Myerson, J. W., Hood, E. D., Patel, P., Brenner, J. S., & Muzykantov, V. R. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.023 · Cited by 77
Moghimi, S. M., Simberg, D., Papini, E., & Farhangrazi, Z. S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.012 · Cited by 75
Signaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease
Lian, H., & Zheng, H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13424 · Cited by 77
McFadyen, J. D., Zeller, J., Potempa, L. A., Pietersz, G. A., Eisenhardt, S. U., & Peter, K. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-41769-7_20 · Cited by 79
Moghimi, S. M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.11.006 · Cited by 72
Regulation of the complement system and immunological tolerance in pregnancy
Teirilä, L., Heikkinen‐Eloranta, J., Kotimaa, J. P., Meri, S., & Lokki, A. I. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101337 · Cited by 75
The Complement System in Lupus Nephritis
Birmingham, D. J., & Hebert, L. A. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.08.006 · Cited by 69
Complement Receptors in Myeloid Cell Adhesion and Phagocytosis
Dustin, M. L. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0034-2016 · Cited by 68
Moghimi, S. M., Simberg, D., Skotland, T., Yaghmur, A., & Hunter, A. C. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258012 · Cited by 64
Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy
Mandava, N., Tirado, V., Geiger, M. D., Patnaik, J. L., Frazer‐Abel, A. A., Lynch, A. M., Mandava, N., Palestine, A. G., Holers, V. M., Wagner, B. D., et al. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.11.39 · Cited by 63
Self-citationExpanding horizons in complement drug discovery: challenges and emerging strategies
Harris, C. L. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0655-8 · Cited by 63
Proteotranscriptomics Reveal Signaling Networks in the Ovarian Cancer Microenvironment
Worzfeld, T., Finkernagel, F., Reinartz, S., Konzer, A., Adhikary, T., Nist, A., Stiewe, T., Wagner, U. A. G., Looso, M., Graumann, J., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000400 · Cited by 61
Complement Activation Is a Prominent Feature of MOGAD
Keller, C. W., Lopez, J. A., Wendel, E., Ramanathan, S., Groß, C. C., Klotz, L., Reindl, M., Dale, R. C., Wiendl, H., Rostasy, K. M., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26226 · Cited by 60
The complex functioning of the complement system in xenotransplantation
Zhou, H., Hara, H., & Cooper, D. K. C. (2019) · Xenotransplantation · doi:10.1111/xen.12517 · Cited by 59
Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection
Chong, A. S., Rothstein, D. M., Safa, K., & Riella, L. V. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15323 · Cited by 57
Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody
Sampei, Z., Haraya, K., Tachibana, T., Fukuzawa, T., Shida-Kawazoe, M., Gan, S. W., Shimizu, Y., Ruike, Y., Feng, S., Kuramochi, T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209509 · Cited by 57
ARGX-117, a therapeutic complement inhibiting antibody targeting C2
de Walle, I. V., Silence, K., Budding, K., de Ven, L. V., Dijkxhoorn, K., de Zeeuw, E., Yildiz, C., Gabriëls, S., Percier, J.-M., Wildemann, J., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.028 · Cited by 54
The relationship of circulating proteins in early pregnancy with preterm birth
Lynch, A. M., Wagner, B. D., Deterding, R. R., Giclas, P. C., Gibbs, R. S., Janoff, E. N., Holers, V. M., & Santoro, N. F. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.11.001 · Cited by 54
Self-citationWang, G., Chen, F., Banda, N. K., Holers, V. M., Wu, L., Moghimi, S. M., & Simberg, D. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00418 · Cited by 54
Self-citationTsao, L.-C., Crosby, E. J., Trotter, T. N., Wei, J.-P., Wang, T., Yang, X. Y., Summers, A. N., Lei, G., Rabiola, C. A., Chodosh, L. A., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.155636 · Cited by 57
Complement System: An Immunotherapy Target in Colorectal Cancer
Talaat, I. M., Elemam, N. M., & Saber-Ayad, M. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.810993 · Cited by 54
Activation of C3a receptor is required in cigarette smoke-mediated emphysema
Yuan, X., Shan, M., You, R., Frazier, M. V., Hong, M. J., Wetsel, R. A., Drouin, S. M., Seryshev, A. B., Song, L.-Z., Cornwell, L. D., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.118 · Cited by 51
Mechanisms of SARS‐CoV‐2‐induced lung vascular disease: potential role of complement
Stenmark, K. R., Frid, M. G., Gerasimovskaya, E. V., Zhang, H., McCarthy, M. K., Thurman, J. M., & Morrison, T. E. (2021) · Pulmonary Circulation · doi:10.1177/20458940211015799 · Cited by 53
A quantitative lateral flow assay to detect complement activation in blood
Schramm, E. C., Staten, N. R., Zhang, Z., Bruce, S. S., Kellner, C. P., Atkinson, J. P., Kyttaris, V. C., Tsokos, G. C., Petri, M., Connolly, E. S., et al. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.01.024 · Cited by 52
Peng, G., & Fadeel, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114422 · Cited by 54
The hijackers guide to escaping complement: Lessons learned from pathogens
Ermert, D., Ram, S., & Laabei, M. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.07.018 · Cited by 51
Moreno‐Rodríguez, M., Perez, S. E., Nadeem, M., Malek‐Ahmadi, M. H., & Mufson, E. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1723-x · Cited by 53
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease
Ozen, A., Kasap, N., Vujkovic-Cvijin, I., Apps, R., Cheung, F., Karakoç-Aydıner, E., Akkelle, B. Ş., Sarı, S., Tutar, E., Özçay, F., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00830-z · Cited by 48
Kisserli, A., Schneider, N., Audonnet, S., Tabary, T., Goury, A., Cousson, J., Mahmoudi, R., Bani‐Sadr, F., Kanagaratnam, L., Jolly, D., et al. (2021) · Immunobiology · doi:10.1016/j.imbio.2021.152093 · Cited by 56
Metadata
- Authors
- Holers, V. M.
- Affiliations
- University of Colorado Anschutz (US)
- Corresponding author
- Holers, V. Michael
- ORCID
- Holers, V. Michael
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2014-03-21
- Volume
- 32
- Issue
- 1
- Pages
- 433-459
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2163243965
- Cited by
- 430
- References
- 152
- Citations by year
- 2026: 21 · 2025: 25 · 2024: 33 · 2023: 27 · 2022: 39 · 2021: 48 · 2020: 46 · 2019: 42 · 2018: 34 · 2017: 40 · 2016: 36 · 2015: 27 · 2014: 10
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Lupus Research Alliance
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R21AI105717)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR051749)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Keywords
- complement system, complement receptors, complement activation, complement regulation, efferocytosis, bacterial infection, inflammatory diseases, autoimmune disease, degenerative diseases, rare diseases, genetic research, complement therapeutics, tissue damage
- MeSH terms
- Animals, Carrier Proteins, Complement System Proteins, Complement Activation, Disease Models, Animal, Disease Susceptibility, Humans, Protein Binding, Receptors, Complement, Signal Transduction, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review